Transparent and ethical business practices
Our support provided to healthcare professionals and organisations is governed by industry and company regulations.
As a member of Medicines Australia (MA), Roche’s pharmaceutical division abides by the MA Code of Conduct, including the transparent disclosure of reportable payments to healthcare professionals for provision of expert services (e.g. giving a lecture, chairing an educational meeting, providing advice as part of an Advisory Board); or sponsorship to attend medical education events.
For more information about the MA Code and reporting requirements, visit the MA website.
Healthcare professionals listed in Roche’s reports can request further information from [email protected].
Download a transfe of value report
|1 November 2019 - 30 April 2020
|1 November 2018 - 30 April 2019
|1 May 2018 - 31 October 2018||CSV|
|1 November 2017 - 30 April 2018||CSV|
|1 May 2017 - 31 October 2017||CSV|
|1 November 2016 - 30 April 2017||CSV|
|1 May 2016 - 31 October 2016||CSV|
|1 November 2015 - 30 April 2016||CSV|
Third Party Sponsorship
Reportable payments made to healthcare professionals are detailed in six-monthly reports, in accordance with MA Code requirements and Australia’s privacy legislation. Prior to publication, each healthcare professional listed in the reports is afforded the opportunity to verify information. Data will be publicly available for three years from the date of publication. To comply with privacy obligations, reports may be amended from time to time. Any use or disclosure of data in the reports by a third party is the responsibility of that third party, who must comply with Australian privacy laws.